UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.963

Sortiert nach

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Annals of oncology, 2018-06, Vol.29 (6), p.1402-1408

2018

Volltextzugriff (PDF)

Dental extraction without stopping single or dual antiplatelet therapy: results of a retrospective cohort study

International journal of oral and maxillofacial surgery, 2016-10, Vol.45 (10), p.1293-1298

2016

Volltextzugriff (PDF)

Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients

Clinical microbiology and infection, 2018-09, Vol.24 (9), p.997-1003

2018

Volltextzugriff (PDF)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

Annals of oncology, 2020-03, Vol.31 (3), p.334-351

2020

Volltextzugriff (PDF)

The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients

Journal of viral hepatitis, 2018-05, Vol.25 (5), p.590-597

2018

Volltextzugriff (PDF)

Hepatitis B surface antigen loss and clinical outcomes between HBeAg‐negative cirrhosis patients who discontinued or continued nucleoside analogue therapy

Journal of viral hepatitis, 2017-07, Vol.24 (7), p.599-607

2017

Volltextzugriff (PDF)

Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience

Clinical microbiology and infection, 2016-01, Vol.22 (1), p.95.e1-95.e7

2016

Volltextzugriff (PDF)

Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study

Clinical microbiology and infection, 2017-07, Vol.23 (7), p.464-469

2017

Volltextzugriff (PDF)

Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy

British journal of cancer, 2013-10, Vol.109 (9), p.2481-2488

2013

Volltextzugriff (PDF)

A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study

Clinical microbiology and infection, 2014-02, Vol.20 (2), p.O90-O100

2014

Volltextzugriff (PDF)

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

British journal of cancer, 2010-09, Vol.103 (7), p.954-960

2010

Volltextzugriff (PDF)

Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis

Journal of viral hepatitis, 2006-06, Vol.13 (6), p.409-414

2006

Volltextzugriff (PDF)

Role of hepatitis C virus substitutions and interleukin-28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response-guided therapy

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.761-769

2013

Volltextzugriff (PDF)

Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study

The Journal of infectious diseases, 2012-08, Vol.206 (4), p.469-477

2012

Volltextzugriff (PDF)

Factors related to postoperative pain among patients who underwent radiofrequency ablation of hepatocellular carcinoma

Clinical radiology, 2013-06, Vol.68 (6), p.600-607

2013

Volltextzugriff (PDF)

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

Alimentary Pharmacology and Therapeutics, 2007-05, Vol.25 (9), p.1029-1037

2007

Volltextzugriff (PDF)

Association between obesity, hypertriglyceridemia and low hepatitis B viral load

International Journal of Obesity, 2013-03, Vol.37 (3), p.410-415

2013

Volltextzugriff (PDF)

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

JNCI : Journal of the National Cancer Institute, 2008-08, Vol.100 (16), p.1134-1143

2008

Volltextzugriff (PDF)

A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients

Digestive and liver disease, 2009-06, Vol.41 (6), p.431-441

2009

Volltextzugriff (PDF)

Mutations in the interferon sensitivity‐determining region (nonstructural 5A amino acid 2209–2248) in patients with hepatitis C‐1b infection and correlating response to combined therapy of pegylated interferon and ribavirin

Alimentary pharmacology & therapeutics, 2008-01, Vol.27 (1), p.72-79

2008

Volltextzugriff (PDF)

Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma

Journal of viral hepatitis, 2008-01, Vol.15 (1), p.58-65

2008

Volltextzugriff (PDF)

Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan

Scandinavian journal of gastroenterology, 2003, Vol.38 (1), p.95-101

2003

Volltextzugriff (PDF)

Fatal Hepatic Failure After Emergence of the Hepatitis B Virus Mutant During Lamivudine Therapy in a Patient with Liver Cirrhosis

Scandinavian journal of gastroenterology, 2002, Vol.37 (3), p.366-369

2002

Volltextzugriff (PDF)

Influencing factors of preoperative pulmonary function in elderly patients undergoing rotator cuff surgery

Beijing da xue xue bao. Journal of Peking University. Yi xue ban, 2021-10, Vol.53 (5), p.902-906

2021

Volltextzugriff (PDF)

72 OUTCOMES OF COMBINATION OF HEPATITIS B IMMUNOGLOBULIN AND HEPATITIS B VACCINATION IN HIGH-RISK NEWBORNS BORN TO HBEAG-POSITIVE MOTHERS

Journal of hepatology, 2012-04, Vol.56, p.S31-S32

2012

Volltextzugriff (PDF)

1 – 25 von 1.963

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.408)
Mit Volltextzugriff
(1.463)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.001)
Humans
(698)
Life Sciences & Biomedicine
(506)
Female
(450)
Male
(439)
Physical Sciences
(390)
Adult
(293)
Middle Aged
(291)
Technology
(237)
Biological And Medical Sciences
(235)
Physics
(218)
Animals
(207)
Aged
(195)
Medical Sciences
(189)
Exact Sciences And Technology
(164)
Materials Science
(135)
Materials Science, Multidisciplinary
(105)
Adolescent
(101)
Chemistry
(101)
Retrospective Studies
(101)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Dental extraction without stopping single or dual antiplatelet therapy: results of a retrospective cohort study

Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients

Hepatitis B surface antigen loss and clinical outcomes between HBeAg‐negative cirrhosis patients who discontinued or continued nucleoside analogue therapy

Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience

Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study

Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy

A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis

Role of hepatitis C virus substitutions and interleukin-28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response-guided therapy

Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study

Factors related to postoperative pain among patients who underwent radiofrequency ablation of hepatocellular carcinoma

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

Association between obesity, hypertriglyceridemia and low hepatitis B viral load

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients

Mutations in the interferon sensitivity‐determining region (nonstructural 5A amino acid 2209–2248) in patients with hepatitis C‐1b infection and correlating response to combined therapy of pegylated interferon and ribavirin

Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma

Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan

Fatal Hepatic Failure After Emergence of the Hepatitis B Virus Mutant During Lamivudine Therapy in a Patient with Liver Cirrhosis

Influencing factors of preoperative pulmonary function in elderly patients undergoing rotator cuff surgery

72 OUTCOMES OF COMBINATION OF HEPATITIS B IMMUNOGLOBULIN AND HEPATITIS B VACCINATION IN HIGH-RISK NEWBORNS BORN TO HBEAG-POSITIVE MOTHERS

Suchergebnisse filtern